Skip to content
Moderna, Inc., a pioneer in the field of messenger RNA (mRNA) medicines and vaccines, has revealed its global public health strategy, which includes four […]
Moderna targets 15 pathogens in its Global Public Health Strategy Read More »
The U.S. Food and Drug Administration (FDA) on March 4 authorized a shelf-life extension, from six to nine months, for the Janssen COVID-19 vaccine
Janssen COVID-19 vaccine’s shelf-life extended to 9 months Read More »
People in rural areas of the United States have received COVID-19 vaccines at a lower rate than people in urban areas, and the problem
Gap between urban and rural rates of COVID-19 vaccination grows Read More »
It’s been two years since COVID-19 was officially named a pandemic by the World Health Organization (WHO), and we are finally moving from a pandemic
BIO Exclusive: COVID-19, from pandemic to endemic? Read More »
An international effort to ensure that we can develop vaccines against the next pandemic in as little as 100 days gained support and more
Next goal: Developing pandemic-busting vaccines in 100 days Read More »
Autoimmune diseases are a wide range of related illnesses in which a person’s immune system attacks their own tissues. In normal conditions, antibodies are
Autoimmune diseases made more challenging by COVID-19 Read More »
On the occasion of International Women’s Day, March 8, it is appropriate to remember the women who have made significant contributions to the advancement
Women‘s contributions to biotech outpace their recognition Read More »
The antiviral drug Molnupiravir was added to the World Health Organization (WHO) guidelines on COVID 19 therapeutics, the WHO announced last week. The WHO
Molnupiravir is first antiviral drug included in WHO’s COVID guidelines Read More »
The Food and Drug Administration (FDA) on Friday announced approval of using nivolumab in certain procedures for treating non-small cell lung cancer (NSCLC), the
FDA approves Opdivo alongside chemo for the most common lung cancer Read More »
COVID-19 vaccination hesitancy dropped more rapidly among Black people than among white people since December 2020, though the rate of vaccination is still lower
Study: COVID vaccine hesitancy declined more rapidly among Black Americans Read More »
